Cornerstone Therapeutics to Host Second Quarter 2013 Conference Call

Cornerstone Therapeutics to Host Second Quarter 2013 Conference Call

ID: 283190

(firmenpresse) - CARY, NC -- (Marketwired) -- 07/30/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Tuesday, August 6, 2013, to discuss its financial results for the second quarter of 2013 ended June 30, 2013. Financial results are expected to be released before the open of the U.S. financial markets on Tuesday, August 6, 2013.

To participate in the live conference call, please dial 888-539-3612 (U.S. callers) or 719-325-2484 (international callers), and provide passcode 6619268. A live webcast of the call will also be available through the of the Company's website. Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The conference call and the webcast will be archived for 30 days. The telephone replay of the call will be available approximately two hours after completion of the call by dialing 888-203-1112 (U.S. callers) or 719-457-0820 (international callers), and providing passcode 6619268.



Cornerstone Therapeutics Inc. (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of the Company's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas; and generate revenues by marketing approved generic products through the Company's wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. For more information, visit .



Investor Relations Contact:
Josh Franklin
Vice President
Strategy and Business Development
+1-919-678-6520


Media Relations Contact:
FleishmanHillard




Andrea Moody
+1-919-457-0743

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Insys Therapeutics to Report Second Quarter 2013 Financial Results on August 13 Medifocus, Inc. Obtains New US Patent Covering the Use of Heat for the Controlled Release/Activation of Drugs and Genes
Bereitgestellt von Benutzer: Marketwired
Datum: 30.07.2013 - 21:01 Uhr
Sprache: Deutsch
News-ID 283190
Anzahl Zeichen: 0

contact information:
Town:

CARY, NC



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 229 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cornerstone Therapeutics to Host Second Quarter 2013 Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Cornerstone Therapeutics (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cornerstone Therapeutics



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z